Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 34
Filter
Add more filters










Publication year range
1.
Mol Psychiatry ; 20(11): 1448-59, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26239290

ABSTRACT

Tonically active cholinergic interneurons (TANs) from the nucleus accumbens (NAc) are centrally involved in reward behavior. TANs express a vesicular glutamate transporter referred to as VGLUT3 and thus use both acetylcholine and glutamate as neurotransmitters. The respective roles of each transmitter in the regulation of reward and addiction are still unknown. In this study, we showed that disruption of the gene that encodes VGLUT3 (Slc17a8) markedly increased cocaine self-administration in mice. Concomitantly, the amount of dopamine (DA) release was strongly augmented in the NAc of VGLUT3(-/-) mice because of a lack of signaling by metabotropic glutamate receptors. Furthermore, dendritic spines and glutamatergic synaptic transmission on medium spiny neurons were increased in the NAc of VGLUT3(-/-) mice. Increased DA and glutamate signaling in the NAc are hallmarks of addiction. Our study shows that TANs use glutamate to reduce DA release and decrease reinforcing properties of cocaine in mice. Interestingly, we also observed an increased frequency of rare variations in SLC17A8 in a cohort of severe drug abusers compared with controls. Our findings identify VGLUT3 as an unexpected regulator of drug abuse.


Subject(s)
Cocaine-Related Disorders/genetics , Cocaine-Related Disorders/pathology , Dopamine/metabolism , Genetic Predisposition to Disease/genetics , Glutamic Acid/metabolism , Nucleus Accumbens/metabolism , Signal Transduction/physiology , Vesicular Glutamate Transport Proteins/genetics , Action Potentials/drug effects , Action Potentials/genetics , Adult , Animals , Cocaine/pharmacology , Conditioning, Operant/drug effects , Dopamine Uptake Inhibitors/pharmacology , Humans , Mice , Mice, Transgenic , Middle Aged , Neurons/drug effects , Neurons/ultrastructure , Nucleus Accumbens/cytology , Nucleus Accumbens/drug effects , Opioid-Related Disorders/genetics , Opioid-Related Disorders/pathology , Self Administration , Synaptic Potentials/drug effects , Synaptic Potentials/genetics , Vesicular Glutamate Transport Proteins/deficiency
2.
Braz J Med Biol Res ; 46(10): 844-54, 2013 Oct.
Article in English | MEDLINE | ID: mdl-24141612

ABSTRACT

Impaired cholinergic neurotransmission can affect memory formation and influence sleep-wake cycles (SWC). In the present study, we describe the SWC in mice with a deficient vesicular acetylcholine transporter (VAChT) system, previously characterized as presenting reduced acetylcholine release and cognitive and behavioral dysfunctions. Continuous, chronic ECoG and EMG recordings were used to evaluate the SWC pattern during light and dark phases in VAChT knockdown heterozygous (VAChT-KDHET, n=7) and wild-type (WT, n=7) mice. SWC were evaluated for sleep efficiency, total amount and mean duration of slow-wave, intermediate and paradoxical sleep, as well as the number of awakenings from sleep. After recording SWC, contextual fear-conditioning tests were used as an acetylcholine-dependent learning paradigm. The results showed that sleep efficiency in VAChT-KDHET animals was similar to that of WT mice, but that the SWC was more fragmented. Fragmentation was characterized by an increase in the number of awakenings, mainly during intermediate sleep. VAChT-KDHET animals performed poorly in the contextual fear-conditioning paradigm (mean freezing time: 34.4±3.1 and 44.5±3.3 s for WT and VAChT-KDHET animals, respectively), which was followed by a 45% reduction in the number of paradoxical sleep episodes after the training session. Taken together, the results show that reduced cholinergic transmission led to sleep fragmentation and learning impairment. We discuss the results on the basis of cholinergic plasticity and its relevance to sleep homeostasis. We suggest that VAChT-KDHET mice could be a useful model to test cholinergic drugs used to treat sleep dysfunction in neurodegenerative disorders.


Subject(s)
Behavior, Animal/physiology , Cholinergic Agents/metabolism , Maze Learning/physiology , Sleep Stages/physiology , Synaptic Transmission/physiology , Wakefulness/physiology , Animals , Male , Mice , Mice, Knockout , Models, Animal
3.
Braz. j. med. biol. res ; 46(10): 844-854, 24/set. 2013. graf
Article in English | LILACS | ID: lil-688554

ABSTRACT

Impaired cholinergic neurotransmission can affect memory formation and influence sleep-wake cycles (SWC). In the present study, we describe the SWC in mice with a deficient vesicular acetylcholine transporter (VAChT) system, previously characterized as presenting reduced acetylcholine release and cognitive and behavioral dysfunctions. Continuous, chronic ECoG and EMG recordings were used to evaluate the SWC pattern during light and dark phases in VAChT knockdown heterozygous (VAChT-KDHET, n=7) and wild-type (WT, n=7) mice. SWC were evaluated for sleep efficiency, total amount and mean duration of slow-wave, intermediate and paradoxical sleep, as well as the number of awakenings from sleep. After recording SWC, contextual fear-conditioning tests were used as an acetylcholine-dependent learning paradigm. The results showed that sleep efficiency in VAChT-KDHET animals was similar to that of WT mice, but that the SWC was more fragmented. Fragmentation was characterized by an increase in the number of awakenings, mainly during intermediate sleep. VAChT-KDHET animals performed poorly in the contextual fear-conditioning paradigm (mean freezing time: 34.4±3.1 and 44.5±3.3 s for WT and VAChT-KDHET animals, respectively), which was followed by a 45% reduction in the number of paradoxical sleep episodes after the training session. Taken together, the results show that reduced cholinergic transmission led to sleep fragmentation and learning impairment. We discuss the results on the basis of cholinergic plasticity and its relevance to sleep homeostasis. We suggest that VAChT-KDHET mice could be a useful model to test cholinergic drugs used to treat sleep dysfunction in neurodegenerative disorders.


Subject(s)
Animals , Male , Mice , Behavior, Animal/physiology , Cholinergic Agents/metabolism , Maze Learning/physiology , Sleep Stages/physiology , Synaptic Transmission/physiology , Wakefulness/physiology , Mice, Knockout , Models, Animal
4.
Toxicon ; 60(5): 907-18, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22659539

ABSTRACT

PnTx3-4 is a toxin isolated from the venom of the spider Phoneutria nigriventer that blocks N-, P/Q-, and R-type voltage-gated calcium channels and has great potential for clinical applications. In this report we used the SUMO system to express large amounts of recombinant PnTx3-4 peptide, which was found in both soluble and insoluble fractions of bacterial extracts. We purified the recombinant toxin from both fractions and showed that the recombinant peptide showed biological activity similar to the native PnTx3-4. In silico analysis of the primary sequence of PnTx3-4 indicated that the peptide conforms to all the criteria of a knottin scaffold. Additionally, circular dichroism spectrum analysis of the recombinant PnTx3-4 predicted that the toxin structure is composed of approximately 53% turns/unordered, 31% α-helix and 16% ß-strand, which is consistent with predicted model of the PnTx3-4 knottin scaffold available at the knottin database (http://knottin.cbs.cnrs.fr). These studies provide the basis for future large scale production and structure-function investigation of PnTx3-4.


Subject(s)
Calcium Channels/metabolism , Neuropeptides/metabolism , Recombinant Proteins/metabolism , Spider Venoms/metabolism , Amino Acid Sequence , Analysis of Variance , Animals , Circular Dichroism , Molecular Sequence Data , Neuropeptides/genetics , Neuropeptides/isolation & purification , Oligonucleotides/genetics , Plasmids/genetics , Protein Folding , Sequence Analysis, DNA , Synaptosomes/metabolism
5.
Genes Brain Behav ; 10(4): 457-64, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21401875

ABSTRACT

The neurotransmitter acetylcholine (ACh) plays a crucial role in both the central and peripheral nervous system. Central cholinergic transmission is important for cognitive functions and cholinergic disruptions have been associated with different neural disorders. We here tested the role of cholinergic transmission in basic cognitive functions, i.e. in prepulse inhibition (PPI) and short-term habituation (STH) as well as long-term habituation (LTH) of startle using mice with a 65% knockdown (KD) of the vesicular ACh transporter (VAChT). These mice are slow in refilling cholinergic synaptic transmitter vesicles, leading to a reduced cholinergic tone. Prepulse inhibition has been assumed to be mediated by cholinergic projections from the midbrain to the reticular formation. Surprisingly, PPI and STH were normal in these mice, whereas LTH was disrupted. This disruption could be rescued by pre-testing injections of the ACh esterase inhibitor galantamine, but not by post-testing injections. The lack of a PPI deficit might be because of the fact that VAChT KD mice show disruptions mainly in prolonged cholinergic activity, therefore the transient activation by prepulse processing might not be sufficient to deplete synaptic vesicles. The disruption of LTH indicates that the latter depends on a tonic cholinergic inhibition. Future experiments will address which cholinergic cell group is responsible for this effect.


Subject(s)
Acetylcholine/metabolism , Habituation, Psychophysiologic/genetics , Sensory Gating/genetics , Vesicular Acetylcholine Transport Proteins/genetics , Acoustic Stimulation , Animals , Mice , Mice, Knockout , Reflex, Startle/genetics , Synaptic Transmission/genetics , Synaptic Vesicles/genetics , Synaptic Vesicles/metabolism , Vesicular Acetylcholine Transport Proteins/metabolism
6.
Genes Brain Behav ; 8(1): 23-35, 2009 Feb.
Article in English | MEDLINE | ID: mdl-18778400

ABSTRACT

Storage of acetylcholine in synaptic vesicles plays a key role in maintaining cholinergic function. Here we used mice with a targeted mutation in the vesicular acetylcholine transporter (VAChT) gene that reduces transporter expression by 40% to investigate cognitive processing under conditions of VAChT deficiency. Motor skill learning in the rotarod revealed that VAChT mutant mice were slower to learn this task, but once they reached maximum performance they were indistinguishable from wild-type mice. Interestingly, motor skill performance maintenance after 10 days was unaffected in these mutant mice. We also tested whether reduced VAChT levels affected learning in an object recognition memory task. We found that VAChT mutant mice presented a deficit in memory encoding necessary for the temporal order version of the object recognition memory, but showed no alteration in spatial working memory, or spatial memory in general when tested in the Morris water maze test. The memory deficit in object recognition memory observed in VAChT mutant mice could be reversed by cholinesterase inhibitors, suggesting that learning deficits caused by reduced VAChT expression can be ameliorated by restoring ACh levels in the synapse. These data indicate an important role for cholinergic tone in motor learning and object recognition memory.


Subject(s)
Learning Disabilities/genetics , Vesicular Acetylcholine Transport Proteins/biosynthesis , Vesicular Acetylcholine Transport Proteins/genetics , Animals , Dose-Response Relationship, Drug , Fluorescent Antibody Technique , Learning Disabilities/psychology , Maze Learning/physiology , Mental Recall/physiology , Mice , Mice, Inbred C57BL , Mice, Mutant Strains , Motor Activity/physiology , Motor Skills/physiology , Nerve Endings/metabolism , Postural Balance/physiology , Psychomotor Performance/physiology , Recognition, Psychology/physiology
7.
Braz J Med Biol Res ; 37(6): 929-35, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15264038

ABSTRACT

T-type Ca2+ channels are important for cell signaling by a variety of cells. We report here the electrophysiological and molecular characteristics of the whole-cell Ca2+ current in GH3 clonal pituitary cells. The current inactivation at 0 mV was described by a single exponential function with a time constant of 18.32 +/- 1.87 ms (N = 16). The I-V relationship measured with Ca2+ as a charge carrier was shifted to the left when we applied a conditioning pre-pulse of up to -120 mV, indicating that a low voltage-activated current may be present in GH3 cells. Transient currents were first activated at -50 mV and peaked around -20 mV. The half-maximal voltage activation and the slope factors for the two conditions are -35.02 +/- 2.4 and 6.7 +/- 0.3 mV (pre-pulse of -120 mV, N = 15), and -27.0 +/- 0.97 and 7.5 +/- 0.7 mV (pre-pulse of -40 mV, N = 9). The 8-mV shift in the activation mid-point was statistically significant (P < 0.05). The tail currents decayed bi-exponentially suggesting two different T-type Ca2+ channel populations. RT-PCR revealed the presence of alpha1G (CaV3.1) and alpha1I (CaV3.3) T-type Ca2+ channel mRNA transcripts.


Subject(s)
Calcium Channels, T-Type/physiology , Pituitary Gland/cytology , Calcium Channels, T-Type/genetics , Cell Line , Clone Cells , Electrophysiology , Humans , Reverse Transcriptase Polymerase Chain Reaction
8.
Braz. j. med. biol. res ; 37(6): 929-935, Jun. 2004. ilus, tab, graf
Article in English | LILACS | ID: lil-359901

ABSTRACT

T-type Ca2+ channels are important for cell signaling by a variety of cells. We report here the electrophysiological and molecular characteristics of the whole-cell Ca2+ current in GH3 clonal pituitary cells. The current inactivation at 0 mV was described by a single exponential function with a time constant of 18.32 ñ 1.87 ms (N = 16). The I-V relationship measured with Ca2+ as a charge carrier was shifted to the left when we applied a conditioning pre-pulse of up to -120 mV, indicating that a low voltage-activated current may be present in GH3 cells. Transient currents were first activated at -50 mV and peaked around -20 mV. The half-maximal voltage activation and the slope factors for the two conditions are -35.02 ñ 2.4 and 6.7 ñ 0.3 mV (pre-pulse of -120 mV, N = 15), and -27.0 ñ 0.97 and 7.5 ñ 0.7 mV (pre-pulse of -40 mV, N = 9). The 8-mV shift in the activation mid-point was statistically significant (P < 0.05). The tail currents decayed bi-exponentially suggesting two different T-type Ca2+ channel populations. RT-PCR revealed the presence of a1G (CaV3.1) and a1I (CaV3.3) T-type Ca2+ channel mRNA transcripts.


Subject(s)
Humans , Calcium Channels, T-Type , Pituitary Gland , Cell Line , Clone Cells , Electrophysiology , Reverse Transcriptase Polymerase Chain Reaction , RNA
9.
J Neurochem ; 87(1): 136-46, 2003 Oct.
Article in English | MEDLINE | ID: mdl-12969261

ABSTRACT

Synthesis of acetylcholine depends on the plasma membrane uptake of choline by a high affinity choline transporter (CHT1). Choline uptake is regulated by nerve impulses and trafficking of an intracellular pool of CHT1 to the plasma membrane may be important for this regulation. We have generated a hemagglutinin (HA) epitope tagged CHT1 to investigate the organelles involved with intracellular trafficking of this protein. Expression of CHT1-HA in HEK 293 cells establishes Na+-dependent, hemicholinium-3 sensitive high-affinity choline transport activity. Confocal microscopy reveals that CHT1-HA is found predominantly in intracellular organelles in three different cell lines. Importantly, CHT1-HA seems to be continuously cycling between the plasma membrane and endocytic organelles via a constitutive clathrin-mediated endocytic pathway. In a neuronal cell line, CHT1-HA colocalizes with the early endocytic marker green fluorescent protein (GFP)-Rab 5 and with two markers of synaptic-like vesicles, VAMP-myc and GFP-VAChT, suggesting that in cultured cells CHT1 is present mainly in organelles of endocytic origin. Subcellular fractionation and immunoisolation of organelles from rat brain indicate that CHT1 is present in synaptic vesicles. We propose that intracellular CHT1 can be recruited during stimulation to increase choline uptake in nerve terminals.


Subject(s)
Clathrin/metabolism , Endocytosis/physiology , Endosomes/metabolism , Hemicholinium 3/pharmacology , Membrane Transport Proteins/metabolism , Synaptic Vesicles/metabolism , Vesicular Transport Proteins , Animals , Carrier Proteins/genetics , Carrier Proteins/metabolism , Cell Line , Humans , Kidney/cytology , Kidney/metabolism , Membrane Proteins/genetics , Membrane Proteins/metabolism , Membrane Transport Proteins/drug effects , Membrane Transport Proteins/genetics , Mice , Neurons/cytology , Neurons/metabolism , R-SNARE Proteins , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Synaptosomes/metabolism , Vesicular Acetylcholine Transport Proteins
10.
Toxicon ; 41(3): 305-13, 2003 Mar 01.
Article in English | MEDLINE | ID: mdl-12565753

ABSTRACT

PnTx3-1 is a peptide isolated from the venom of the spider Phoneutria nigriventer that specifically inhibits A-type K(+) currents (I(A)) in GH(3) cells. Here we used a bacterial expression system to produce an NH(2)-extended mutant of PnTx3-1 (ISEF-PnTx3-1) and tested whether the toxin is functional. The recombinant toxin was purified from bacterial extracts by a combination of affinity and ion-exchange chromatography. The recombinant toxin blocked A-type K(+) currents in GH(3) cells in a fashion similar to that observed with the wild-type toxin purified from the spider venom. These results suggest that recombinant cDNA methods provide a novel source for the production of functional Phoneutria toxins. The recombinant ISEF-PnTx3-1 should be useful for further understanding of the role of A-type K(+) currents in biological processes.


Subject(s)
Neuropeptides/biosynthesis , Potassium Channel Blockers , Recombinant Fusion Proteins/biosynthesis , Spider Venoms/genetics , Amino Acid Sequence , Animals , Chemical Fractionation , Chromatography, Affinity , Chromatography, Ion Exchange , Cloning, Molecular , Molecular Sequence Data , Neuropeptides/genetics , Neuropeptides/pharmacology , Patch-Clamp Techniques , Potassium Channels/drug effects , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/pharmacology , Spider Venoms/pharmacology , Tumor Cells, Cultured
11.
Neurochem Int ; 41(5): 291-9, 2002 Nov.
Article in English | MEDLINE | ID: mdl-12176069

ABSTRACT

Acetylcholine is one of the major modulators of brain functions and it is the main neurotransmitter at the peripheral nervous system. Modulation of acetylcholine release is crucial for nervous system function. Moreover, dysfunction of cholinergic transmission has been linked to a number of pathological conditions. In this manuscript, we review the cellular mechanisms involved with regulation of acetylcholine synthesis and storage. We focus on how phosphorylation of key cholinergic proteins can participate in the physiological regulation of cholinergic nerve-endings.


Subject(s)
Acetylcholine/metabolism , Membrane Transport Proteins , Vesicular Transport Proteins , Acetylcholine/biosynthesis , Animals , Carrier Proteins/metabolism , Choline O-Acetyltransferase/metabolism , Humans , Synaptic Vesicles/enzymology , Synaptic Vesicles/metabolism , Vesicular Acetylcholine Transport Proteins
12.
J Neurochem ; 78(5): 1104-13, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11553684

ABSTRACT

Synaptic vesicle proteins are suggested to travel from the trans-Golgi network to active zones via tubulovesicular organelles, but the participation of different populations of endosomes in trafficking remains a matter of debate. Therefore, we generated a green fluorescent protein (GFP)-tagged version of the vesicular acetylcholine transporter (VAChT) and studied the localization of VAChT in organelles in the cell body and varicosities of living cholinergic cells. GFP-VAChT is distributed to both early and recycling endosomes in the cell body and is also observed to accumulate in endocytic organelles within varicosities of SN56 cells. GFP-VAChT positive organelles in varicosities are localized close to plasma membrane and are labeled with FM4-64 and GFP-Rab5, markers of endocytic vesicles and early endosomes, respectively. A GFP-VAChT mutant lacking a dileucine endocytosis motif (leucine residues 485 and 486 changed to alanine residues) accumulated at the plasma membrane in SN56 cells. This endocytosis-defective GFP-VAChT mutant is localized primarily at the somal plasma membrane and exhibits reduced neuritic targeting. Furthermore, the VAChT mutant did not accumulate in varicosities, as did VAChT. Our data suggest that clathrin-mediated internalization of VAChT to endosomes at the cell body might be involved in proper sorting and trafficking of VAChT to varicosities. We conclude that genesis of competent cholinergic secretory vesicles depends on multiple interactions of VAChT with endocytic proteins.


Subject(s)
Acetylcholine/metabolism , Carrier Proteins/genetics , Carrier Proteins/pharmacokinetics , Membrane Transport Proteins , Neurons/metabolism , Vesicular Transport Proteins , Amino Acid Sequence , Animals , Clathrin-Coated Vesicles/metabolism , Endocytosis/physiology , Gene Expression/physiology , Green Fluorescent Proteins , Indicators and Reagents/pharmacokinetics , Luminescent Proteins/genetics , Luminescent Proteins/pharmacokinetics , Molecular Sequence Data , Mutagenesis/physiology , Neurons/cytology , Synaptic Transmission/physiology , Transfection , Tumor Cells, Cultured , Vesicular Acetylcholine Transport Proteins
13.
Ann Hum Genet ; 65(Pt 6): 549-63, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11851985

ABSTRACT

The mtDNA haplogroup L3e, which is identified by the restriction site +2349 MboI within the Afro-Eurasian superhaplogroup L3 (-3592 HpaI), is omnipresent in Africa but virtually absent in Eurasia (except for neighbouring areas with limited genetic exchange). L3e was hitherto poorly characterised in terms of HVS-I motifs, as the ancestral HVS-I type of L3e cannot be distinguished from the putative HVS-I ancestor of the entire L3 (differing from the CRS by a transition at np 16223). An MboI screening at np 2349 of a large number of Brazilian and Caribbean mtDNAs (encompassing numerous mtDNAs of African ancestry), now reveals that L3e is subdivided into four principal clades, each characterised by a single mutation in HVS-I, with additional support coming from HVS-II and partial RFLP analysis. The apparently oldest of these clades (transition at np 16327) occurs mainly in central Africa and was probably carried to southern Africa with the Bantu expansion(s). The most frequent clade (transition at np 16320) testifies to a pronounced expansion event in the mid-Holocene and seems to be prominent in many Bantu groups from all of Africa. In contrast, one clade (transition at np 16264) is essentially restricted to Atlantic western Africa (including Cabo Verde). We propose a tentative L3e phylogeny that is based on 197 HVS-I sequences. We conclude that haplogroup L3e originated in central or eastern Africa about 46,000 (+/-14,000) years ago, and was a hitchhiker of much later dispersal and local expansion events, with the rise of food production and iron smelting. Enforced migration of African slaves to the Americas translocated L3e mitochondria, the descendants of which in Brazil and the Caribbean still reflect their different regional African ancestries.


Subject(s)
DNA, Mitochondrial/genetics , Haplotypes , Phylogeny , Africa/ethnology , Brazil , Caribbean Region , Databases, Genetic , Emigration and Immigration/history , History, Ancient , Time
15.
Am J Hum Genet ; 67(2): 444-61, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10873790

ABSTRACT

We have analyzed 247 Brazilian mtDNAs for hypervariable segment (HVS)-I and selected restriction fragment-length-polymorphism sites, to assess their ancestry in different continents. The total sample showed nearly equal amounts of Native American, African, and European matrilineal genetic contribution but with regional differences within Brazil. The mtDNA pool of present-day Brazilians clearly reflects the imprints of the early Portuguese colonization process (involving directional mating), as well as the recent immigrant waves (from Europe) of the last century. The subset of 99 mtDNAs from the southeastern region encompasses nearly all mtDNA haplogroups observed in the total Brazilian sample; for this regional subset, HVS-II was analyzed, providing, in particular, some novel details of the African mtDNA phylogeny.


Subject(s)
DNA, Mitochondrial/genetics , Phylogeny , Regulatory Sequences, Nucleic Acid/genetics , White People/genetics , Africa/ethnology , Asia/ethnology , Brazil , DNA, Mitochondrial/classification , Europe/ethnology , Fathers , Female , Gene Frequency/genetics , Gene Pool , Geography , Haplotypes/genetics , Humans , Indians, South American/genetics , Male , Molecular Sequence Data , Mothers , Polymorphism, Restriction Fragment Length
16.
J Neurochem ; 74(6): 2425-35, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10820203

ABSTRACT

The present experiments investigated the trafficking of the vesicular acetylcholine transporter (VAChT) tagged with the enhanced green fluorescent protein (EGFP) in living cholinergic cells (SN56). The EGFP-VAChT chimera was located in endosomal-like compartments in the soma of SN56 cells, and it was also targeted to varicosities of neurites. In contrast, EGFP alone in cells was soluble in the cytoplasm. The C-terminal cytoplasmic tail of VAChT has been implicated in targeting of VAChT to synaptic vesicles; thus, we have examined the role of the C-terminal region in the trafficking to varicosities. A C-terminal fragment tagged with EGFP appeared to be selectively accumulated in varicosities when expressed in SN56 cells. Interestingly, the protein was not freely soluble in the cytosol, and it presented a punctate pattern of expression. However, EGFP-C terminus did not present this peculiar pattern of expression in a nonneuronal cell line (HEK 293). Moreover, the C-terminal region of VAChT did not seem to be essential for VAChT trafficking, as a construct that lacks the C-terminal tail was, similar to EGFP-VAChT, partially targeted to endocytic organelles in the soma and sorted to varicosities. These experiments visualize VAChT for the first time in living cells and suggest that there might be multiple signals that participate in trafficking of VAChT to sites of synaptic vesicle accumulation.


Subject(s)
Carrier Proteins/genetics , Carrier Proteins/metabolism , Endocytosis/physiology , Membrane Transport Proteins , Microscopy, Confocal/methods , Neurons/metabolism , Synaptic Vesicles/metabolism , Vesicular Transport Proteins , Animals , Fluorescent Antibody Technique , Genes, Reporter , Green Fluorescent Proteins , Humans , Indicators and Reagents/metabolism , Kidney/cytology , Luminescent Proteins/genetics , Mice , Neuroblastoma , Neurons/cytology , Patch-Clamp Techniques , Plasmids , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Transfection , Tumor Cells, Cultured , Vesicular Acetylcholine Transport Proteins
17.
Toxicon ; 38(10): 1443-9, 2000 Oct.
Article in English | MEDLINE | ID: mdl-10758278

ABSTRACT

From a Phoneutria nigriventer venom gland cDNA library several clones coding for the insect specific neurotoxin Tx4(6-1) were isolated. cDNA analysis showed that the encoded protein contained three distinct segments, comprising a signal sequence of 16 amino acids, followed by a glutamate-rich sequence of 18 amino acids and, finally, the coding region for the mature toxin. The deduced amino acid sequence for the mature polypeptide was identical to the protein sequence determined chemically. In addition, two new putative toxins called Pn4A and Pn4B were characterized and their predicted complete amino acid sequence revealed approximately 78% similarity to Tx4(6-1).


Subject(s)
DNA, Complementary/genetics , Insecticides , Neurotoxins/genetics , Peptides/genetics , Spider Venoms/genetics , Spiders , Amino Acid Sequence , Animals , Base Sequence , Cloning, Molecular , DNA, Complementary/isolation & purification , Exocrine Glands/chemistry , Exocrine Glands/metabolism , Molecular Sequence Data , Neurotoxins/chemistry , Spider Venoms/chemistry
18.
Neuroreport ; 10(13): 2783-7, 1999 Sep 09.
Article in English | MEDLINE | ID: mdl-10511440

ABSTRACT

4-Aminobenzovesamicol was used to test whether activation of protein kinase C protects the vesicular acetylcholine transporter from interaction with vesamicol-like drugs. The essentially irreversible vesamicol analog inhibits the release of newly synthesized [3H]acetylcholine from stimulated hippocampal slices. Prior activation of protein kinase C with a phorbol ester prevented the inhibition of [3H]acetylcholine release, but activation of protein kinase C after the exposure to the irreversible analog did not prevent the effect of the drug. Binding of 4-aminobenzovesamicol in hippocampal synaptosomes, assayed using [3H]vesamicol and back-titration, was decreased by activation of protein kinase C prior to analog exposure but not by activation subsequent to exposure. We propose that phosphorylation of the vesicular acetylcholine transporter prevents the binding of vesamicol-like drugs.


Subject(s)
Carrier Proteins/metabolism , Membrane Transport Proteins , Piperidines/metabolism , Vesicular Transport Proteins , Acetylcholine/antagonists & inhibitors , Acetylcholine/biosynthesis , Animals , Electric Stimulation , Enzyme Activation/physiology , Female , Hippocampus/metabolism , In Vitro Techniques , Male , Piperidines/pharmacology , Protein Kinase C/metabolism , Rats , Rats, Wistar , Vesicular Acetylcholine Transport Proteins
19.
J Neurochem ; 73(5): 1881-93, 1999 Nov.
Article in English | MEDLINE | ID: mdl-10537046

ABSTRACT

The expression and localization of the vesicular acetylcholine transporter in a septal cell line, SN56, were investigated. Immunoprecipitation and immunoblot analysis of postnuclear supernatants indicated that this cell line expresses reasonable amounts of the transporter. Immunofluorescence and confocal microscopy experiments showed that the vesicular transporter is present in varicosities and also in the cell body of differentiated cells. Varicosities have the potential to be functional sites of transmitter release because they responded to depolarization with calcium influx through voltage-gated calcium channels and expressed the synaptic proteins synaptotagmin, SV2, synaptophysin, and a subunit of P/Q calcium channels. In the soma of SN56 cells, the transporter immunoreactivity was similar to that for synaptotagmin, and it colocalized with synaptophysin, but it did not colocalize with SV2. Labeling for SV2 appeared prominently in a defined perinuclear structure, whereas the two former proteins were widely distributed in the soma, where several endocytic compartments could be identified with the vital dye FM4-64. These data suggest that distinct synaptic vesicle proteins exist in different subcellular compartments, and consequently they may follow distinct pathways in neurites before reaching sites of transmitter storage and release in SN56 cells.


Subject(s)
Calcium-Binding Proteins , Calcium/metabolism , Carrier Proteins/genetics , Exocytosis , Membrane Transport Proteins , Septum of Brain/metabolism , Signal Transduction , Vesicular Transport Proteins , Animals , Calcium Channels/physiology , Carrier Proteins/analysis , Gene Expression , Humans , Ion Channel Gating , Male , Membrane Glycoproteins/analysis , Mice , Mice, Inbred BALB C , Nerve Tissue Proteins/analysis , Neurotransmitter Agents/analysis , Rats , Septum of Brain/chemistry , Synaptic Transmission , Synaptophysin/analysis , Synaptotagmins , Vesicular Acetylcholine Transport Proteins
20.
Hum Biol ; 71(2): 245-59, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10222646

ABSTRACT

We investigated 245 white Brazilians for the presence of the 9-bp deletion in the intergenic COII/tRNALys region of the mitochondrial DNA (mtDNA) and found the deletion in 21 individuals (8.6% of the sample). Because white Brazilians are believed to be predominantly of European descent and this marker is rare in Europe, we established the geographic origin of these 21 mtDNA sequences by sequencing the hypervariable segment I of the mtDNA control region and by performing an RFLP analysis. Only 1 European mtDNA lineage was identified. On the other hand, 16 of the individuals had matrilineages of Amerindian origin and 4 had African mtDNA haplotypes. These results demonstrate that in the formation of the present-day white Brazilian population there was a significant contribution of Amerindian and African matrilineages. Although these data initially appear surprising, they agree well with the historical records of Brazilian colonization.


Subject(s)
DNA, Mitochondrial/genetics , Gene Deletion , Haplotypes/genetics , Immunoglobulin Variable Region/genetics , Polymorphism, Genetic/genetics , White People/genetics , Africa/ethnology , Brazil , Cluster Analysis , Europe/ethnology , Genetic Testing , Humans , Indians, South American/genetics , Phylogeny , Polymorphism, Restriction Fragment Length
SELECTION OF CITATIONS
SEARCH DETAIL
...